Health Trials

Ocular Hypertension (OH)

2

Review clinical trials related to Ocular Hypertension (OH). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study

This study is to establish non-inferiority of a preservative free formulation of Bimatoprost ophthalmic solution 0.01% (YSBP) of YS Life Science Co., Ltd. compared to LUMIGAN® (bimatoprost ophthalmic solution) 0.01% of AbbVie INC in subjects with primary open angle glaucoma (POAG) or ocular hypertension.

Participants needed: 600
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: YS Life Science Co., Ltd.Updated: Jun 22, 2026Locations: 16
Eligibility criteria

Subjects willing and able to provide voluntary informed consent and to follow pr... [+14]

Female subjects with positive pregnancy test or lactating or planning a pregnanc... [+24]

Read more
Status: Recruiting

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Glaukos CorporationUpdated: Feb 27, 2026Locations: 1
Eligibility criteria

Diagnosis of Open-angle glaucoma [+1]

Subject who is breast-feeding or pregnant

Read more